Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Oral ciclosporin A and topical treatments both reduce hair loss and scaling in dogs with sebaceous adenitis, but using both together is most effective.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

The terrier dog with pituitary-dependent hyperadrenocorticism was successfully treated with mitotane.

Midazolam's seizure prevention is partly due to increased neurosteroid production.

Cilostazol may help hair grow and could be a new treatment for hair loss.

The research created new azasteroids and pseudoazulenyl nitrones, which could be useful in medicine.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Ritlecitinib is safe and may effectively treat alopecia areata.

Acitretin is effective for certain types of psoriasis, safe for long-term use, and often combined with other treatments.

New microneedles deliver drugs through the skin accurately and effectively.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Rats developed lung issues from the drugs, but these cleared quickly after stopping them.

Treating epilepsy is complex, requiring careful drug choice and patient adherence to manage seizures and side effects.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

The committee decided not to approve the drug due to low effectiveness and high risks.

The combination of calcipotriene and betamethasone is more effective and has fewer side effects for treating psoriasis.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Calotropis gigantea and Tridax procumbens extracts reduce inflammation more effectively than low-dose Ibuprofen.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.